APO RESEARCH · REPORT
Heart Defect Closure Devices
Heart defect closure devices are permanent implants designed to close defects between chambers of the heart or a patent ductus arteriosus. These are self-expandable, self-centering umbrella-like devices. The design and shape of the devices vary, as does their exact mode of deployment. They are implanted in the defect in a cardiac catheterization laboratory, through catheters inserted into either a vein or an artery (transcatheter or percutaneous approach). There are several types of defects, which include atrial septal defect (ASD), persistent patent ductus arteriosus (PDA), ventricular septal defect (VSD), patent foramen ovale (PFO), and left atrial appendage (LAA). Most of these defects are congenital, but can occur after a myocardial infarction or can be the result of a surgical repair of other congenital heart defects.
Product & engineering
Understand the product.
Heart defect closure devices are permanent implants designed to close defects between chambers of the heart or a patent ductus arteriosus. These are self-expandable, self-centering umbrella-like devices. The design and shape of the devices vary, as does their exact mode of deployment. They are implanted in the defect in a cardiac catheterization laboratory, through catheters inserted into either a vein or an artery (transcatheter or percutaneous approach). There are several types of defects, which include atrial septal defect (ASD), persistent patent ductus arteriosus (PDA), ventricular septal defect (VSD), patent foramen ovale (PFO), and left atrial appendage (LAA). Most of these defects are congenital, but can occur after a myocardial infarction or can be the result of a surgical repair of other congenital heart defects.
Selected research
Industry Research
Heart Defect Closure Devices Industry Research Report 2026
Market perspective
Heart defect closure devices are permanent implants designed to close defects between chambers of the heart or a patent ductus arteriosus. These are self-expandable, self-centering umbrella-like devices. The design and shape of the devices vary, as does their exact mode of deployment. They are implanted in the defect in a cardiac catheterization laboratory, through catheters inserted into either a vein or an artery (transcatheter or percutaneous approach). There are several types of defects, which include atrial septal defect (ASD), persistent patent ductus arteriosus (PDA), ventricular septal defect (VSD), patent foramen ovale (PFO), and left atrial appendage (LAA). Most of these defects are congenital, but can occur after a myocardial infarction or can be the result of a surgical repair of other congenital heart defects.
Global Heart Defect Closure Devices key players include St. Jude Medical, Starway, LifeTech, etc. Global top three manufacturers hold a share about 85%.
United States is the largest market, with a share about 70%, followed by Europe and China, both have a share over 25 percent.
Read the full market overview
In terms of product, ASD Closure Devices is the largest segment, with a share about 40%.
Report Scope
This report quantifies the global Heart Defect Closure Devices market in terms of revenue (US$ million) and, where applicable, sales volume (units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Heart Defect Closure Devices Market by Company
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore and Associates
Starway
Coherex Medical
Cardia
MicroPort
Heart Defect Closure Devices Segment by Type
ASD Closure Devices
VSD Closure Devices
PDA Closure Devices
PFO Closure Devices
LAA Closure Devices
Heart Defect Closure Devices Segment by Application
Hospitals
Clinics
Heart Defect Closure Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heart Defect Closure Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Heart Defect Closure Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heart Defect Closure Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Heart Defect Closure Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Heart Defect Closure Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Heart Defect Closure Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ASD Closure Devices
- VSD Closure Devices
- PDA Closure Devices
- PFO Closure Devices
- LAA Closure Devices
Applications
- Hospitals
- Clinics
Companies covered
- Abbott
- Boston Scientific
- LifeTech
- Lepu Medical
- Occlutech
- W. L. Gore and Associates
- Starway
- Coherex Medical
- Cardia
- MicroPort
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Heart Defect Closure Devices Market Size (2021-2032)
- 2.2.2 Global Heart Defect Closure Devices Sales (2021-2032)
- 2.2.3 Global Heart Defect Closure Devices Market Average Price (2021-2032)
- 2.3 Heart Defect Closure Devices by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 ASD Closure Devices
- 2.3.3 VSD Closure Devices
- 2.3.4 PDA Closure Devices
- 2.3.5 PFO Closure Devices
- 2.3.6 LAA Closure Devices
- 2.4 Heart Defect Closure Devices by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Heart Defect Closure Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Heart Defect Closure Devices Sales (units) of Manufacturers (2021-2026)
- 3.3 Global Heart Defect Closure Devices Revenue of Manufacturers (2021-2026)
- 3.4 Global Heart Defect Closure Devices Average Price by Manufacturers (2021-2026)
- 3.5 Global Heart Defect Closure Devices Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Heart Defect Closure Devices, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Heart Defect Closure Devices, Product Type & Application
- 3.8 Global Manufacturers of Heart Defect Closure Devices, Established Date
- 3.9 Global Heart Defect Closure Devices Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Company Information
- 4.1.2 Abbott Business Overview
- 4.1.3 Abbott Heart Defect Closure Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Heart Defect Closure Devices Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 Boston Scientific
- 4.2.1 Boston Scientific Company Information
- 4.2.2 Boston Scientific Business Overview
- 4.2.3 Boston Scientific Heart Defect Closure Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Boston Scientific Heart Defect Closure Devices Product Portfolio
- 4.2.5 Boston Scientific Recent Developments
- 4.3 LifeTech
- 4.3.1 LifeTech Company Information
- 4.3.2 LifeTech Business Overview
- 4.3.3 LifeTech Heart Defect Closure Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 LifeTech Heart Defect Closure Devices Product Portfolio
- 4.3.5 LifeTech Recent Developments
- 4.4 Lepu Medical
- 4.4.1 Lepu Medical Company Information
- 4.4.2 Lepu Medical Business Overview
- 4.4.3 Lepu Medical Heart Defect Closure Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Lepu Medical Heart Defect Closure Devices Product Portfolio
- 4.4.5 Lepu Medical Recent Developments
- 4.5 Occlutech
- 4.5.1 Occlutech Company Information
- 4.5.2 Occlutech Business Overview
- 4.5.3 Occlutech Heart Defect Closure Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Occlutech Heart Defect Closure Devices Product Portfolio
- 4.5.5 Occlutech Recent Developments
- 4.6 W. L. Gore and Associates
- 4.6.1 W. L. Gore and Associates Company Information
- 4.6.2 W. L. Gore and Associates Business Overview
- 4.6.3 W. L. Gore and Associates Heart Defect Closure Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 W. L. Gore and Associates Heart Defect Closure Devices Product Portfolio
- 4.6.5 W. L. Gore and Associates Recent Developments
- 4.7 Starway
- 4.7.1 Starway Company Information
- 4.7.2 Starway Business Overview
- 4.7.3 Starway Heart Defect Closure Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Starway Heart Defect Closure Devices Product Portfolio
- 4.7.5 Starway Recent Developments
- 4.8 Coherex Medical
- 4.8.1 Coherex Medical Company Information
- 4.8.2 Coherex Medical Business Overview
- 4.8.3 Coherex Medical Heart Defect Closure Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Coherex Medical Heart Defect Closure Devices Product Portfolio
- 4.8.5 Coherex Medical Recent Developments
- 4.9 Cardia
- 4.9.1 Cardia Company Information
- 4.9.2 Cardia Business Overview
- 4.9.3 Cardia Heart Defect Closure Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Cardia Heart Defect Closure Devices Product Portfolio
- 4.9.5 Cardia Recent Developments
- 4.10 MicroPort
- 4.10.1 MicroPort Company Information
- 4.10.2 MicroPort Business Overview
- 4.10.3 MicroPort Heart Defect Closure Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 MicroPort Heart Defect Closure Devices Product Portfolio
- 4.10.5 MicroPort Recent Developments
5 Global Heart Defect Closure Devices Market Scenario by Region
- 5.1 Global Heart Defect Closure Devices Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Heart Defect Closure Devices Sales by Region: 2021-2032
- 5.2.1 Global Heart Defect Closure Devices Sales by Region: 2021-2026
- 5.2.2 Global Heart Defect Closure Devices Sales by Region: 2027-2032
- 5.3 Global Heart Defect Closure Devices Revenue by Region: 2021-2032
- 5.3.1 Global Heart Defect Closure Devices Revenue by Region: 2021-2026
- 5.3.2 Global Heart Defect Closure Devices Revenue by Region: 2027-2032
- 5.4 North America Heart Defect Closure Devices Market Facts & Figures by Country
- 5.4.1 North America Heart Defect Closure Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Heart Defect Closure Devices Sales by Country (2021-2032)
- 5.4.3 North America Heart Defect Closure Devices Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Heart Defect Closure Devices Market Facts & Figures by Country
- 5.5.1 Europe Heart Defect Closure Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Heart Defect Closure Devices Sales by Country (2021-2032)
- 5.5.3 Europe Heart Defect Closure Devices Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Heart Defect Closure Devices Market Facts & Figures by Country
- 5.6.1 Asia Pacific Heart Defect Closure Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Heart Defect Closure Devices Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Heart Defect Closure Devices Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Heart Defect Closure Devices Market Facts & Figures by Country
- 5.7.1 South America Heart Defect Closure Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Heart Defect Closure Devices Sales by Country (2021-2032)
- 5.7.3 South America Heart Defect Closure Devices Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Heart Defect Closure Devices Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Heart Defect Closure Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Heart Defect Closure Devices Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Heart Defect Closure Devices Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Heart Defect Closure Devices Sales by Type (2021-2032)
- 6.1.1 Global Heart Defect Closure Devices Sales by Type (2021-2032) & (units)
- 6.1.2 Global Heart Defect Closure Devices Sales Market Share by Type (2021-2032)
- 6.2 Global Heart Defect Closure Devices Revenue by Type (2021-2032)
- 6.2.1 Global Heart Defect Closure Devices Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Heart Defect Closure Devices Revenue Market Share by Type (2021-2032)
- 6.3 Global Heart Defect Closure Devices Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Heart Defect Closure Devices Sales by Application (2021-2032)
- 7.1.1 Global Heart Defect Closure Devices Sales by Application (2021-2032) & (units)
- 7.1.2 Global Heart Defect Closure Devices Sales Market Share by Application (2021-2032)
- 7.2 Global Heart Defect Closure Devices Revenue by Application (2021-2032)
- 7.2.1 Global Heart Defect Closure Devices Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Heart Defect Closure Devices Revenue Market Share by Application (2021-2032)
- 7.3 Global Heart Defect Closure Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Heart Defect Closure Devices Value Chain Analysis
- 8.1.1 Heart Defect Closure Devices Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Heart Defect Closure Devices Production Mode & Process
- 8.2 Heart Defect Closure Devices Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Heart Defect Closure Devices Distributors
- 8.2.3 Heart Defect Closure Devices Customers
9 Global Heart Defect Closure Devices Analyzing Market Dynamics
- 9.1 Heart Defect Closure Devices Industry Trends
- 9.2 Heart Defect Closure Devices Industry Drivers
- 9.3 Heart Defect Closure Devices Industry Opportunities and Challenges
- 9.4 Heart Defect Closure Devices Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst